English

Somaxon Pharmaceuticals, Inc.

EDGAR

Quarterly report (10-Q) · filed 2012-11-01

32 filing records in this dataset, filed from 2005-11-10 to 2012-11-01. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.13 million USD

2012 Q3 · USD

Exact inputs and evidence

Revenue: 2134000 USD Source

Operating margin

-210.07%

2012 Q3 · %

Exact inputs and evidence

Operating Income: -4483000 USD Source
Revenue: 2134000 USD Source

Operating cash flow

-1.98 million USD

2012 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -5563000 USD Source
Operating Cash Flow: -3584000 USD Source

Cash and cash equivalents: 8.16 million USD 2012-09-30 Source
Exact value

8156000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 7.19 million shares 2012-09-30 Source
Exact value

7191000 shares

Reported share-count change

-85.01% · -40.8 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

47985000 shares · 2011-09-30· Source
7191000 shares · 2012-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-19 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Net income: -59280000 USD · 2011-01-01 – 2011-12-31 Source
Net income: -49018000 USD · 2011-01-01 – 2011-09-30 Source
Net income: -2117000 USD · 2012-01-01 – 2012-03-31 Source
Net income: -2199000 USD · 2012-04-01 – 2012-06-30 Source
Net income: -4469000 USD · 2012-07-01 – 2012-09-30 Source

Operating cash flow

-14.8 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Operating cash flow: -49489000 USD · 2011-01-01 – 2011-12-31 Source
Operating cash flow: -40227000 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: -2914000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -3584000 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -2914000 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -5563000 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -3584000 USD · 2012-01-01 – 2012-06-30 Source

Capital expenditure

413 thousand USD

2011-01-01 – 2011-12-31

Exact inputs and evidence

Capital expenditure: 85000 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 318000 USD · 2011-01-01 – 2011-06-30 Source
Capital expenditure: 85000 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 413000 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 318000 USD · 2011-01-01 – 2011-06-30 Source
Capital expenditure: 413000 USD · 2011-01-01 – 2011-12-31 Source
Capital expenditure: 413000 USD · 2011-01-01 – 2011-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-11-01.

Financial data available through: 2011-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2011-12-31
Net income: 9 of 11 periods available· newest 2011-12-31
Operating cash flow: 9 of 11 periods available· newest 2011-12-31
Capital expenditure: 9 of 11 periods available· newest 2011-12-31
Total assets: 8 of 11 periods available· newest 2011-12-31
Total liabilities: 3 of 11 periods available· newest 2011-12-31
Current assets: 8 of 11 periods available· newest 2011-12-31
Current liabilities: 8 of 11 periods available· newest 2011-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2011-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 20.47 million

Prior period

−USD 38.81 million

2010-01-01 – 2010-12-31
Current period

−USD 59.28 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-59280000 − -38813000 = -20467000 USD

-38813000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-59280000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Somaxon Pharmaceuticals, Inc. · 2011-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Year-over-year change in Net income: -20467000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -59280000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#27362 Filing: 000119312512105189 Input fundies:NetIncome: -38813000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#27480 Filing: 000119312512105189
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 19.79 million

Prior period

−USD 29.7 million

2010-01-01 – 2010-12-31
Current period

−USD 49.49 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-49489000 − -29696000 = -19793000 USD

-29696000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-49489000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Somaxon Pharmaceuticals, Inc. · 2011-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Year-over-year change in Operating cash flow: -19793000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -49489000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#33830 Filing: 000119312512105189 Input fundies:OperatingCashFlow: -29696000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34006 Filing: 000119312512105189
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+5.4%

Prior period

USD 392,000

2010-01-01 – 2010-12-31
Current period

USD 413,000

2011-01-01 – 2011-12-31

Exact inputs and evidence

413000 − 392000 = 21000 USD

392000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
413000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Somaxon Pharmaceuticals, Inc. · 2011-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Year-over-year change in Capital expenditure: 21000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 413000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34357 Filing: 000119312512105189 Input fundies:CapitalExpenditure: 392000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34530 Filing: 000119312512105189
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2003-01-01 – 2003-12-31	−USD 1.46 million Exact value Exact value: -1463182 USD 2003-01-01 – 2003-12-31: -1463182 USD Inspect Net Income Open source Share or cite Citation for Net Income · Somaxon Pharmaceuticals, Inc. · 2003-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Net Income: -1463182 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1463182 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-06-000257.txt#16192 The citation records this snapshot. The page link may show a newer release later.	−USD 1.37 million Exact value Exact value: -1367699 USD 2003-01-01 – 2003-12-31: -1367699 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Somaxon Pharmaceuticals, Inc. · 2003-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Operating Cash Flow: -1367699 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1367699 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-06-000257.txt#16476 The citation records this snapshot. The page link may show a newer release later.	USD 8,492 Exact value Exact value: 8492 USD 2003-01-01 – 2003-12-31: 8492 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Somaxon Pharmaceuticals, Inc. · 2003-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Capital Expenditure: 8492 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8492 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-06-000257.txt#16539 The citation records this snapshot. The page link may show a newer release later.	−USD 1.38 million Calculation and evidence -1367699 − 8492 USD Exact free cash flow: -1376191 USD 2003-01-01 – 2003-12-31: -1367699 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 8492 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Somaxon Pharmaceuticals, Inc. · 2003-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Free cash flow: -1376191 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1367699 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-06-000257.txt#16476 Input fundies:CapitalExpenditure: 8492 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-06-000257.txt#16539 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 13.6 million Exact value Exact value: -13598000 USD 2004-01-01 – 2004-12-31: -13598000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Somaxon Pharmaceuticals, Inc. · 2004-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Net Income: -13598000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13598000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-07-000194.txt#49621 The citation records this snapshot. The page link may show a newer release later.	−USD 10.94 million Exact value Exact value: -10942208 USD 2004-01-01 – 2004-12-31: -10942208 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Somaxon Pharmaceuticals, Inc. · 2004-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Operating Cash Flow: -10942208 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10942208 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-06-000257.txt#16476 The citation records this snapshot. The page link may show a newer release later.	USD 116,338 Exact value Exact value: 116338 USD 2004-01-01 – 2004-12-31: 116338 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Somaxon Pharmaceuticals, Inc. · 2004-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Capital Expenditure: 116338 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 116338 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-06-000257.txt#16539 The citation records this snapshot. The page link may show a newer release later.	−USD 11.06 million Calculation and evidence -10942208 − 116338 USD Exact free cash flow: -11058546 USD 2004-01-01 – 2004-12-31: -10942208 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 116338 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Somaxon Pharmaceuticals, Inc. · 2004-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Free cash flow: -11058546 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10942208 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-06-000257.txt#16476 Input fundies:CapitalExpenditure: 116338 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-06-000257.txt#16539 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 38.49 million Exact value Exact value: -38487000 USD 2005-01-01 – 2005-12-31: -38487000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Somaxon Pharmaceuticals, Inc. · 2005-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Net Income: -38487000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38487000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950134-08-004565.txt#68095 The citation records this snapshot. The page link may show a newer release later.	−USD 23.58 million Exact value Exact value: -23577000 USD 2005-01-01 – 2005-12-31: -23577000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Somaxon Pharmaceuticals, Inc. · 2005-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Operating Cash Flow: -23577000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23577000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950134-08-004565.txt#68864 The citation records this snapshot. The page link may show a newer release later.	USD 143,000 Exact value Exact value: 143000 USD 2005-01-01 – 2005-12-31: 143000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Somaxon Pharmaceuticals, Inc. · 2005-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Capital Expenditure: 143000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 143000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950134-08-004565.txt#69027 The citation records this snapshot. The page link may show a newer release later.	−USD 23.72 million Calculation and evidence -23577000 − 143000 USD Exact free cash flow: -23720000 USD 2005-01-01 – 2005-12-31: -23577000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 143000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Somaxon Pharmaceuticals, Inc. · 2005-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Free cash flow: -23720000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23577000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950134-08-004565.txt#68864 Input fundies:CapitalExpenditure: 143000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950134-08-004565.txt#69027 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 46.41 million Exact value Exact value: -46410000 USD 2006-01-01 – 2006-12-31: -46410000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Somaxon Pharmaceuticals, Inc. · 2006-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Net Income: -46410000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46410000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-09-000121.txt#71212 The citation records this snapshot. The page link may show a newer release later.	−USD 45.57 million Exact value Exact value: -45574000 USD 2006-01-01 – 2006-12-31: -45574000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Somaxon Pharmaceuticals, Inc. · 2006-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Operating Cash Flow: -45574000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45574000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-09-000121.txt#71981 The citation records this snapshot. The page link may show a newer release later.	USD 179,000 Exact value Exact value: 179000 USD 2006-01-01 – 2006-12-31: 179000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Somaxon Pharmaceuticals, Inc. · 2006-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Capital Expenditure: 179000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 179000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-09-000121.txt#72144 The citation records this snapshot. The page link may show a newer release later.	−USD 45.75 million Calculation and evidence -45574000 − 179000 USD Exact free cash flow: -45753000 USD 2006-01-01 – 2006-12-31: -45574000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 179000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Somaxon Pharmaceuticals, Inc. · 2006-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Free cash flow: -45753000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45574000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-09-000121.txt#71981 Input fundies:CapitalExpenditure: 179000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000936392-09-000121.txt#72144 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 26.41 million Exact value Exact value: -26411000 USD 2007-01-01 – 2007-12-31: -26411000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Somaxon Pharmaceuticals, Inc. · 2007-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Net Income: -26411000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26411000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-10-026143.txt#26572 The citation records this snapshot. The page link may show a newer release later.	−USD 21.5 million Exact value Exact value: -21500000 USD 2007-01-01 – 2007-12-31: -21500000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Somaxon Pharmaceuticals, Inc. · 2007-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Operating Cash Flow: -21500000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21500000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-10-026143.txt#26835 The citation records this snapshot. The page link may show a newer release later.	USD 46,000 Exact value Exact value: 46000 USD 2007-01-01 – 2007-12-31: 46000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Somaxon Pharmaceuticals, Inc. · 2007-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Capital Expenditure: 46000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 46000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-10-026143.txt#26907 The citation records this snapshot. The page link may show a newer release later.	−USD 21.55 million Calculation and evidence -21500000 − 46000 USD Exact free cash flow: -21546000 USD 2007-01-01 – 2007-12-31: -21500000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 46000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Somaxon Pharmaceuticals, Inc. · 2007-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Free cash flow: -21546000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21500000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-10-026143.txt#26835 Input fundies:CapitalExpenditure: 46000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-10-026143.txt#26907 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 37.23 million Exact value Exact value: -37227000 USD 2008-01-01 – 2008-12-31: -37227000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Somaxon Pharmaceuticals, Inc. · 2008-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Net Income: -37227000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -37227000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-11-022176.txt#24392 The citation records this snapshot. The page link may show a newer release later.	−USD 29.12 million Exact value Exact value: -29115000 USD 2008-01-01 – 2008-12-31: -29115000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Somaxon Pharmaceuticals, Inc. · 2008-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Operating Cash Flow: -29115000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29115000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-11-022176.txt#24615 The citation records this snapshot. The page link may show a newer release later.	USD 712,000 Exact value Exact value: 712000 USD 2008-01-01 – 2008-12-31: 712000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Somaxon Pharmaceuticals, Inc. · 2008-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Capital Expenditure: 712000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 712000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-11-022176.txt#24672 The citation records this snapshot. The page link may show a newer release later.	−USD 29.83 million Calculation and evidence -29115000 − 712000 USD Exact free cash flow: -29827000 USD 2008-01-01 – 2008-12-31: -29115000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 712000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Somaxon Pharmaceuticals, Inc. · 2008-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Free cash flow: -29827000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29115000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-11-022176.txt#24615 Input fundies:CapitalExpenditure: 712000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/0000950123-11-022176.txt#24672 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 14.44 million Exact value Exact value: -14443000 USD 2009-01-01 – 2009-12-31: -14443000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Somaxon Pharmaceuticals, Inc. · 2009-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Net Income: -14443000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14443000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#27598 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.	−USD 9.56 million Exact value Exact value: -9560000 USD 2009-01-01 – 2009-12-31: -9560000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Somaxon Pharmaceuticals, Inc. · 2009-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Operating Cash Flow: -9560000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9560000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34182 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.	USD 74,000 Exact value Exact value: 74000 USD 2009-01-01 – 2009-12-31: 74000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Somaxon Pharmaceuticals, Inc. · 2009-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Capital Expenditure: 74000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 74000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34703 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.	−USD 9.63 million Calculation and evidence -9560000 − 74000 USD Exact free cash flow: -9634000 USD 2009-01-01 – 2009-12-31: -9560000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 74000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Somaxon Pharmaceuticals, Inc. · 2009-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Free cash flow: -9634000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9560000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34182 Filing: 000119312512105189 Input fundies:CapitalExpenditure: 74000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34703 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 38.81 million Exact value Exact value: -38813000 USD 2010-01-01 – 2010-12-31: -38813000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Somaxon Pharmaceuticals, Inc. · 2010-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Net Income: -38813000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38813000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#27480 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.	−USD 29.7 million Exact value Exact value: -29696000 USD 2010-01-01 – 2010-12-31: -29696000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Somaxon Pharmaceuticals, Inc. · 2010-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Operating Cash Flow: -29696000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29696000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34006 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.	USD 392,000 Exact value Exact value: 392000 USD 2010-01-01 – 2010-12-31: 392000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Somaxon Pharmaceuticals, Inc. · 2010-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Capital Expenditure: 392000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 392000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34530 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.	−USD 30.09 million Calculation and evidence -29696000 − 392000 USD Exact free cash flow: -30088000 USD 2010-01-01 – 2010-12-31: -29696000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 392000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Somaxon Pharmaceuticals, Inc. · 2010-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Free cash flow: -30088000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29696000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34006 Filing: 000119312512105189 Input fundies:CapitalExpenditure: 392000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34530 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 59.28 million Exact value Exact value: -59280000 USD 2011-01-01 – 2011-12-31: -59280000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Somaxon Pharmaceuticals, Inc. · 2011-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Net Income: -59280000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -59280000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#27362 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.	−USD 49.49 million Exact value Exact value: -49489000 USD 2011-01-01 – 2011-12-31: -49489000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Somaxon Pharmaceuticals, Inc. · 2011-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Operating Cash Flow: -49489000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -49489000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#33830 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.	USD 413,000 Exact value Exact value: 413000 USD 2011-01-01 – 2011-12-31: 413000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Somaxon Pharmaceuticals, Inc. · 2011-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Capital Expenditure: 413000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 413000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34357 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.	−USD 49.9 million Calculation and evidence -49489000 − 413000 USD Exact free cash flow: -49902000 USD 2011-01-01 – 2011-12-31: -49489000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 413000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Somaxon Pharmaceuticals, Inc. · 2011-12-31 Somaxon Pharmaceuticals, Inc. (edgar:1339455) Free cash flow: -49902000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T13:48:44Z Snapshot: 6ecc3776dd9cb6d6cd15b5523ee87b497e48e8f6862094d8880b370cb788af5d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1339455?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -49489000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#33830 Filing: 000119312512105189 Input fundies:CapitalExpenditure: 413000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1339455/000119312512105189/somx-20111231.xml#34357 Filing: 000119312512105189 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

32 filings · 514 latest values · 514 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001339455, 1339455, edgar:1339455

Also known as Pernix Sleep, Inc., Somaxon Pharmaceuticals, Inc.

Somaxon Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation